[1]
H. Kusama, Y. Horimoto, K. Takabe, and T. Ishikawa, “Should All Low-Grade Ductal Carcinoma In Situ Be Excised? Implications and Challenges of the COMET Trial”, World J Oncol, vol. 16, no. 2, pp. 239–241, Mar. 2025, doi: 10.14740/wjon2562.